BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Inmagene Forms Celexor Bio with Enhanced anti-ILT7 mAb

"We are pleased to partner with Aditum Bio, a highly innovative venture capital firm established by pharma industry leaders with deep drug development expe...

September 22, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)

Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...

September 15, 2023 | News

deCODE Genetics and Collaborators Reveal Complex Impact of Sequence Variants on Lipid Levels and Heart Disease

Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and The Copenhagen University,...

September 15, 2023 | News

MGI and Bio-Medical Science Partner to Provide Advanced Sequencing Solutions to South Korea

"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality and cost-effective solutio...

September 14, 2023 | News

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...

September 13, 2023 | News

Roche Diagnostics and Burjeel Holdings Join Forces for Enhanced Digital Diagnostics and Patient Care

Roche Diagnostics Middle East FZCO, a global leader in diagnostics, and Burjeel Holdings, one of the largest healthcare services providers in the MENA regi...

September 11, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

Gloria Biosciences' Zimberelimab Approved in China for Recurrent Cervical Cancer

Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...

September 07, 2023 | News

Revvity Introduces Next-Gen Preclinical Imaging Tech for Scientific Breakthroughs

IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versat...

September 06, 2023 | News

Malaysia Healthcare Travel Council Partners with Mayo Clinic for Medical Excellence Advancement

The formal signing ceremony of the MoU was presided over by Farizal B. Jaafar, Acting Chief Executive Officer of MHTC, and Dr. Stacey Rizza, Mayo...

September 06, 2023 | News

Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial

Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...

September 05, 2023 | News

Thyme Care Secures $60M Series B to Scale Cancer Care Beyond the Clinic

Oncology care innovator streamlines a notoriously fragmented healthcare system, reducing gaps and barriers to care for chronically under supp...

September 04, 2023 | News

Bayer Expands Finerenone Clinical Program for Heart Failure

Recruiting approximately 15,000 patients, MOONRAKER is expected to be one of the largest heart failure (HF) study programs to date1,2,3,4 Bayer continue...

September 01, 2023 | News

Stay Connected